…corticosteroid abruptly after longer term treatment. Not giving a stress dose to a patient with adrenal insufficiency during acute illness. Confusing dexamethasone 0.75 mg…

…gradually moves towards the endocardium. As the fibrofatty replacement progresses, the ventricular wall becomes thinner and the ventricle begins to dilate. Approximately 50% of cases…

…These thresholds are also assay dependent. Follow up of known HPA suppression to determine whether replacement can be stopped. The test is not the first…

…kidney then chooses to excrete hydrogen ions instead of potassium, and the urine stays acidic however much bicarbonate is given. Potassium replacement is not the…

…Catapress TTS 3 (0.3 mg/24hrs) Dosage in renal failure and renal replacement therapy: Dose as in normal renal function Adverse effects Excessive sedation…

…patients with severe aortic stenosis, particularly the low flow, low gradient phenotype, or those undergoing aortic valve replacement [1, 5, 10]. A history of increasing…

…leading to marked heat generation, acidosis, and the subsequent development of hyperkalemia. This condition is potentially fatal and necessitates prompt intervention, including sedation and the…

…Valve replacement can be performed with biological or mechanical prostheses. The former is preferred due to the lower risk of thrombosis and evidence demonstrating long…

…1]. Three questions must be answered immediately: 1. Is there obstruction to urine flow? 2. Is the patient hypovolaemic, adequately filled or fluid overloaded? 3…

…target ScvO₂ 70–80 % A low value suggests inadequate oxygen delivery Capillary refill < 3 s Equivalent to lactate guided resuscitation in septic shock Haemoglobin…

…pressure ; gravity is not enough. Lidocaine 10 mg/mL to anaesthetise the marrow cavity in a conscious patient. Fixation material for the intraosseous needle. Procedure…

…m² Advanced renal dysfunction High likelihood of progression to end stage renal disease; preparation for renal replacement therapy is required 5 <15 mL/min/1…

…including pexelizumab, losmapimod and darapladib, failed to demonstrate clinical benefit in the settings studied. Clinical application and patient populations The evidence for anti inflammatory treatment…

…myocardial wall stress and subendocardial ischemia. Neurohormonal activation and vascular and renal abnormalities contribute to sodium and water retention. The interaction between cardiac and renal…

…tachycardia (NCT). Adenosine typically causes a short lasting second or third degree AV block which may be unpleasant to the patient. This side effect lasts…

…and initiation of renal replacement therapy. The study found no significant differences between the two treatment groups with respect to either the primary or secondary…